GenVec Inc (fka GNVC)

[skitahoe]

Clearly the news is what has the Street waiting to see if GNVC can either partner or complete the TNFerade PACT Trial with the existing funds.

This company has the potential of being huge from a pipeline that could potentially bring dozens of drugs into the clinic. The key is either a partnership which give them substantial operating funds, or approval which starts the revenue stream that could build to blockbuster level in a few short years.

I'm not saying TNFerade will achieve billion dollar status on Pancreatic Cancer, perhaps not even if Esophagial and Head and Neck cancers are added. What I am suggesting is that there could be many other cancers that TNFerade will have benefits with, and the beauty of it is it works with other drugs. This will create the sort of scenario where companies with drugs treating cancers will be eager to use TNFerade with their drug as if successful, patients will live longer and thus increase sales in their drug because together they're extending the lives of the patients.

Gary